Associated Effects of Endocrine Disrupting Chemicals (EDCs) on Neuroendocrine Axes and Neurotransmitter Profile in Polycystic Ovarian Syndrome Condition

被引:0
|
作者
Ananthasubramanian P. [1 ]
Ananth S. [1 ]
Kumaraguru S. [1 ]
Barathi S. [1 ]
Santosh W. [2 ]
Vasantharekha R. [1 ]
机构
[1] Endocrine Disruption and Reproductive Toxicology (EDART) Laboratory, Department of Biotechnology, SRM Institute of Science and Technology, Tamil Nadu, Kattankulathur
[2] Department of Advanced Zoology and Biotechnology, Government College for Men, Tamil Nadu, Nandanam, Chennai
关键词
EDCs; Gonadotrophin releasing hormone; Neurotransmitters; PCOS;
D O I
10.1007/s12595-021-00411-4
中图分类号
学科分类号
摘要
Polycystic ovarian syndrome (PCOS) is a highly prevalent heterogeneous disease that affects 1 in 10 women of reproductive age. It causes adverse dysfunction in various systems in the body, conjointly nervous, and endocrine systems, thereby claiming its reputation as a heterogeneous syndrome. Recently the link between endocrine disrupting chemicals (EDCs) and this disease has been studied extensively to understand the potential role of these chemicals in the pathogenesis of PCOS. Relevant literature obtained through a thorough electronic database search were studied and summarized. It was found that PCOS is associated with increased levels of oxidative stress, and inflammation, which contributes to insulin resistance, obesity, and infertility, and all these dysfunctions can be linked with EDC exposure, either directly or indirectly. There are also alterations in the neurotransmitter profile in PCOS, like that observed in animals after EDC exposure, that possibly lead to low self-esteem, anxiety, frequent mood swings, and depression, which are features closely associated with the disease pathology in women. All these dysfunctions resulting from PCOS interact with each other and make it a complex systemic syndrome. Additionally, several EDCs have been found to play a distinct role in the initiation of features that are analogous to PCOS related dysfunction, indicating the possibility of EDC exposure being the initiating factor for PCOS. © 2021, Zoological Society, Kolkata, India.
引用
收藏
页码:378 / 386
页数:8
相关论文
共 12 条
  • [1] Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)
    Eleni Palioura
    Evanthia Diamanti-Kandarakis
    Reviews in Endocrine and Metabolic Disorders, 2015, 16 : 365 - 371
  • [2] Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)
    Palioura, Eleni
    Diamanti-Kandarakis, Evanthia
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2015, 16 (04) : 365 - 371
  • [3] Polycystic Ovary Syndrome: Do Endocrine-Disrupting Chemicals Play a Role?
    Barrett, Emily S.
    Sobolewski, Marissa
    SEMINARS IN REPRODUCTIVE MEDICINE, 2014, 32 (03) : 166 - 176
  • [4] Current Evidence on the Effects of Endocrine-Disrupting Chemicals (EDCs) on Bone Growth and Health
    Shulhai, Anna-Mariia
    Palanza, Paola
    Street, Maria Elisabeth
    EXPOSURE AND HEALTH, 2024, 16 (04) : 1001 - 1025
  • [5] GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile
    Chaudhari, Nirja
    Dawalbhakta, Mitali
    Nampoothiri, Laxmipriya
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2018, 16
  • [6] GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile
    Nirja Chaudhari
    Mitali Dawalbhakta
    Laxmipriya Nampoothiri
    Reproductive Biology and Endocrinology, 16
  • [7] Endocrine and Metabolic Profile of Different Phenotypes of Polycystic Ovarian Syndrome
    Pikee S.
    Shivani S.
    Jayshree B.
    The Journal of Obstetrics and Gynecology of India, 2016, 66 (Suppl 1) : 560 - 566
  • [8] Endocrine-Disrupting Chemicals (EDCs): In Vitro Mechanism of Estrogenic Activation and Differential Effects on ER Target Genes
    Li, Yin
    Luh, Colin J.
    Burns, Katherine A.
    Arao, Yukitomo
    Jiang, Zhongliang
    Teng, Christina T.
    Tice, Raymond R.
    Korach, Kenneth S.
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2013, 121 (04) : 459 - 466
  • [9] Neuroendocrine, neurotransmitter, and gut microbiota imbalance contributing to potential psychiatric disorder prevalence in polycystic ovarian syndrome
    Sarkisian, Karis I.
    Ho, Lananh
    Yang, Jane
    Mandelbaum, Rachel
    Stanczyk, Frank Z.
    F&S REPORTS, 2023, 4 (04): : 337 - 342
  • [10] Clinical, endocrine, and metabolic effects of acarbose, a α-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome
    Tugrul, Semih
    Kutlu, Tayfun
    Pekin, Oya
    Baglam, Elif
    Kiyak, Hueseyin
    Oral, Oezay
    FERTILITY AND STERILITY, 2008, 90 (04) : 1144 - 1148